122 related articles for article (PubMed ID: 10084872)
1. Synthesis and pharmacokinetics of a novel macromolecular prodrug of Tacrolimus (FK506), FK506-dextran conjugate.
Yura H; Yoshimura N; Hamashima T; Akamatsu K; Nishikawa M; Takakura Y; Hashida M
J Control Release; 1999 Jan; 57(1):87-99. PubMed ID: 10084872
[TBL] [Abstract][Full Text] [Related]
2. Development of a macromolecular prodrug of FK 506: III: In vivo disposition of FK 506-dextran conjugate.
Yoshimura N; Yura H; Hamashima T; Oka T; Takakura Y; Hadhida M
Transplant Proc; 1998 Jun; 30(4):1029-30. PubMed ID: 9636415
[No Abstract] [Full Text] [Related]
3. Development of a macromolecular prodrug of FK 506: II: In vitro study for FK 506-dextran conjugate.
Yura H; Yoshimura N; Hamashima T; Oka T; Takakura Y; Hashida M
Transplant Proc; 1998 Jun; 30(4):1031-2. PubMed ID: 9636416
[No Abstract] [Full Text] [Related]
4. Development of a macromolecular prodrug of FK506: I. Synthesis of FK506-dextran conjugate.
Yura H; Yoshimura N; Hamashima T; Oka T; Takakura Y; Hashida M
Transplant Proc; 1998 Nov; 30(7):3598-9. PubMed ID: 9838577
[No Abstract] [Full Text] [Related]
5. Asialoglycoprotein/asialoglycoprotein receptor (AGP-AGPr) interaction is an important mechanism for the uptake of FK506 by hepatocytes.
Marks WH; Ma Y; Yirdaw G; Florence L
Transplantation; 1997 Jan; 63(2):293-8. PubMed ID: 9020333
[TBL] [Abstract][Full Text] [Related]
6. Redox-Responsive Hyaluronic Acid-Tacrolimus Conjugate: Synthesis, Characterization, and
Singh D; Qasam I; Paudwal G; Kotwal P; Behera C; Kumar A; Gupta AP; Nandi U; Yadav G; Gupta PN; Shankar R
ACS Appl Bio Mater; 2023 Feb; 6(2):733-744. PubMed ID: 36646666
[TBL] [Abstract][Full Text] [Related]
7. Preparation, characterization and pharmacokinetic studies of tacrolimus-dimethyl-β-cyclodextrin inclusion complex-loaded albumin nanoparticles.
Gao S; Sun J; Fu D; Zhao H; Lan M; Gao F
Int J Pharm; 2012 May; 427(2):410-6. PubMed ID: 22326299
[TBL] [Abstract][Full Text] [Related]
8. Dextran-methylprednisolone succinate as a prodrug of methylprednisolone: immunosuppressive effects after in vivo administration to rats.
Mehvar R; Hoganson DA
Pharm Res; 2000 Nov; 17(11):1402-7. PubMed ID: 11205734
[TBL] [Abstract][Full Text] [Related]
9. Quantitative relationship between myocardial concentration of tacrolimus and QT prolongation in guinea pigs: pharmacokinetic/pharmacodynamic model incorporating a site of adverse effect.
Minematsu T; Ohtani H; Yamada Y; Sawada Y; Sato H; Iga T
J Pharmacokinet Pharmacodyn; 2001 Dec; 28(6):533-54. PubMed ID: 11999291
[TBL] [Abstract][Full Text] [Related]
10. Physicochemical, pharmacokinetic and pharmacodynamic evaluation of liposomal tacrolimus (FK 506) in rats.
Lee MJ; Straubinger RM; Jusko WJ
Pharm Res; 1995 Jul; 12(7):1055-9. PubMed ID: 7494802
[TBL] [Abstract][Full Text] [Related]
11. Ex vivo assessment of immunosuppression in undiluted whole blood from pigs dosed with tacrolimus (FK506).
Chen YW; Smith ML; Sheets MP; Ballaron SJ; Trevillyan JM; Fey TA; Gauvin DM; Kolano R; Pong MS; Hsieh GC; Bauch J; Marsh K; Carter G; Luly J; Djuric S; Mollison KW
Clin Immunol; 1999 Jan; 90(1):133-40. PubMed ID: 9884362
[TBL] [Abstract][Full Text] [Related]
12. Mechanistic understanding of the different effects of Wuzhi Tablet (Schisandra sphenanthera extract) on the absorption and first-pass intestinal and hepatic metabolism of Tacrolimus (FK506).
Qin XL; Bi HC; Wang XD; Li JL; Wang Y; Xue XP; Chen X; Wang CX; Xu le J; Wang YT; Huang M
Int J Pharm; 2010 Apr; 389(1-2):114-21. PubMed ID: 20097278
[TBL] [Abstract][Full Text] [Related]
13. Strain-specific differences in the effects of cyclosporin A and FK506 on the survival and regeneration of axotomized retinal ganglion cells in adult rats.
Cui Q; Hodgetts SI; Hu Y; Luo JM; Harvey AR
Neuroscience; 2007 May; 146(3):986-99. PubMed ID: 17408862
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of hydrolysis of dextran-methylprednisolone succinate, a macromolecular prodrug of methylprednisolone, in rat blood and liver lysosomes.
Mehvar R; Dann RO; Hoganson DA
J Control Release; 2000 Jul; 68(1):53-61. PubMed ID: 10884579
[TBL] [Abstract][Full Text] [Related]
15. Effect of hematocrit on pharmacokinetics of tacrolimus in adult living donor liver transplant recipients.
Minematsu T; Sugiyama E; Kusama M; Hori S; Yamada Y; Ohtani H; Sawada Y; Sato H; Takayama T; Sugawara Y; Makuuchi M; Iga T
Transplant Proc; 2004 Jun; 36(5):1506-11. PubMed ID: 15251372
[TBL] [Abstract][Full Text] [Related]
16. Effects of water-soluble tacrolimus-PEG conjugate on insulin-dependent diabetes mellitus and systemic lupus erythematosus.
Choi D; Kim BH; Lee MK; Cho H
Arch Pharm Res; 2011 Aug; 34(8):1301-10. PubMed ID: 21910052
[TBL] [Abstract][Full Text] [Related]
17. Evidence that SMS 201-995 enhances the immunosuppressive effect of FK506.
Perego C; Lattuada D; Casnici C; Gatti S; Orsenigo R; Panagiotis S; Franco P; Marelli O
Int J Immunopharmacol; 1998 Sep; 20(9):479-90. PubMed ID: 9818792
[TBL] [Abstract][Full Text] [Related]
18. Carrier and dose effects on the pharmacokinetics of T-0128, a camptothecin analogue-carboxymethyl dextran conjugate, in non-tumor- and tumor-bearing rats.
Harada M; Murata J; Sakamura Y; Sakakibara H; Okuno S; Suzuki T
J Control Release; 2001 Mar; 71(1):71-86. PubMed ID: 11245909
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of tacrolimus (FK506) in paediatric liver transplant recipients.
Wallemacq PE; Furlan V; Möller A; Schäfer A; Stadler P; Firdaous I; Taburet AM; Reding R; Clement De Clety S; De Ville De Goyet J; Sokal E; Lykavieris L; Van Leeuw V; Bernard O; Otte JB; Undre NA
Eur J Drug Metab Pharmacokinet; 1998; 23(3):367-70. PubMed ID: 9842978
[TBL] [Abstract][Full Text] [Related]
20. Studies on an immunosuppressive macrolactam, ascomycin: synthesis of a C-33 hydroxyl derivative.
Kawai M; Gunawardana IW; Mollison KW; Hsieh GC; Lane BC; Luly JR
Bioorg Med Chem Lett; 1998 Apr; 8(8):935-8. PubMed ID: 9871515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
